₹16.15
▼ -0.49 -2.94%
As of 23 Oct 2026 · delayed
BSE Listed
Kabra Drugs Ltd. (524322)
Volume: 58,004Avg Vol 1W: 74,049Avg Vol 1M: 82,12652W Range:₹15.5₹35.52
Key Ratios
Checked just nowMarket Cap₹38 Cr
Current Price₹16.15
Previous Close₹16.64
High / Low (52w)₹35.52 / ₹15.5
Volume58,004
Avg Vol (1W)74,049
Avg Vol (1M)82,126
Stock P/E5.05
Book Value₹12.49
Dividend Yield0%
ROE16.75%
ROA8.8%
Revenue (TTM)—
Revenue Growth—
Profit Margin5.76%
Total Debt—
Shares Outstanding2 Cr
Face Value—
EPS (TTM)₹3.2
P/B1.29
Debt / Equity0.02
50 DMA₹19.81
200 DMA₹24.81
Day change-2.94%
Price Chart
₹16.15▼ 13.45% · 1Y
2025-10-272026-10-23
20-day avg volume: 88K shares
Pros
- Healthy return on equity of 16.8%.
- Company is almost debt-free.
- Revenue grew 14463% YoY.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹7 Cr | ₹20 Cr | ₹30 Cr | ₹35 Cr | ₹46 Cr |
| EBITDA | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr |
| Net Profit | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹93 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹6 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹5 Cr |
| EPS | -0.38 | -0.14 | -0.41 | -0.42 | -0.77 | -1.68 | -0.99 | 2.09 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹5 Cr | ₹25 Cr | ₹86 Cr |
| Total Liabilities | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹57 Cr |
| Equity | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹1 Cr | ₹25 Cr | ₹30 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-5 Cr | ₹-9 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹23 Cr | ₹0 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-5 Cr | ₹-9 Cr |
Shareholding
Promoter 0% Institutions 0% Public 100%
Efficiency & Working Capital
ROCE19.1%
Interest Coverage191.7
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-09-30
Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge—
No. of Shareholders9,727
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Promoter Pledge | — | — | — | — | — | — | — | — | — | — | — | — |
| No. of Shareholders | 7,396 | 7,364 | 7,336 | 7,367 | 7,343 | 7,435 | 7,449 | 8,098 | 8,862 | 9,185 | 9,680 | 9,727 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Kuniamuthur Nanjappan Anand | Public Shareholding | 2.8% | 6,58,500 |
| Somisetty Giridhar Gupta | Public Shareholding | 2.7% | 6,28,756 |
| Somisetty Malathi Latha | Public Shareholding | 2.2% | 5,16,195 |
| Chandraprakash Jamnalal Kabra | Public Shareholding | 1.7% | 4,05,000 |
| Adusumilli Sai Raghava Pratap | Public Shareholding | 1.5% | 3,59,066 |
| Priyam Sachdeva | Public Shareholding | 1.4% | 3,37,184 |
| Narendra Babu Veerla | Public Shareholding | 1.3% | 2,99,920 |
| Akilandeswari Selvamurthy | Public Shareholding | 1.2% | 2,91,816 |
| Rathna Pathengay | Public Shareholding | 1.1% | 2,64,996 |
| Shiva Kumar Adepu | Public Shareholding | 1.1% | 2,53,500 |
| Akansha Gupta | Public Shareholding | 1.1% | 2,52,437 |
| Neha Sagar Shah | Public Shareholding | 1.1% | 2,50,000 |
| Bosco Armando Menezes | Public Shareholding | 1.1% | 2,50,000 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| N Aravind | Executive Director & MD | 2025 |
| Venkatakrishnappa Ananth Kumar | Executive Director / Whole Time Director / CFO | 2025 |
| KUNIAMUTHUR NANJAPPAN ANAND | Executive Director | 2025 |
| Ananthkumar Shilpa | Independent Director | 2025 |
| A Anitha | Independent Director | 2025 |
| Monika Sanwal | Company Sec. & Compli. Officer | 2025 |
| Monam Kapoor | Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing of Drugs | ₹8 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 40 | 24 | 24 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-12 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
Company Information
🌐 www.kabradrugs.com ↗
📍 270 Shastri Market Indore, Indore, Madhya Pradesh, 452007
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search